Cases 21 - 30 of 1,931
In Re: Xarelto (Rivaroxaban) ('310) Patent Litigation
as 1:2021md03017
In Re:
Xarelto (Rivaroxaban) ('310) Patent Litigation
Not Classified By Court:
Clerk of MDL Panel, Lupin Limited, Lupin Pharmaceuticals, Inc. and others
Counter Defendant:
Bayer Pharma AG, Bayer AG and Janssen Pharmaceuticals, Inc.
Defendant:
ScieGen Pharmaceuticals, Inc.
Cause Of Action: 35 U.S.C. § 271 Patent Infringement
Astellas Pharma Inc. et al v. Sandoz Inc. et al
as 1:2020cv01589
Defendant:
Sawai Pharmaceutical Co., Ltd., Cadila Healthcare Ltd. doing business as Zydus Cadila, Apotex Inc. and others
Plaintiff:
Astellas Pharma Inc., Astellas Ireland Co., Ltd. and Astellas Pharma Global Development, Inc.
Cause Of Action: 35 U.S.C. § 271 Patent Infringement
Gilead Sciences, Inc. v. Apotex Inc. et al
as 1:2023cv00775
Plaintiff:
Gilead Sciences, Inc.
Defendant:
Apotex Inc. and Apotex Corp.
Cause Of Action: 35 U.S.C. § 271 Patent Infringement
OYSTER POINT PHARMA, INC. v. APOTEX, INC.,
as 3:2023cv03860
Plaintiff:
OYSTER POINT PHARMA, INC.
Defendant:
APOTEX, INC.,
Cause Of Action: 35 U.S.C. § 271 Patent Infringement
Actelion Pharmaceuticals Ltd et al v. Apotex Inc. et al
as 1:2023cv00734
Plaintiff:
Actelion Pharmaceuticals Ltd and Actelion Pharmaceuticals US, Inc.
Defendant:
Apotex Inc. and Apotex Corp.
Cause Of Action: 35 U.S.C. § 271 Patent Infringement
Merck KGaA et al v. Apotex Inc. et al
as 1:2023cv00655
Plaintiff:
Merck KGaA, Merck Serono SA and Ares Trading SA
Defendant:
Apotex Inc. and Apotex Corp.
Cause Of Action: 35 U.S.C. § 1 Patent Infringement
Otsuka Pharmaceutical Co., Ltd. v. Apotex Inc. et al
as 1:2023cv00710
Plaintiff:
Otsuka Pharmaceutical Co., Ltd.
Defendant:
Apotex Inc. and Apotex Corp.
Cause Of Action: 35 U.S.C. § 271 Patent Infringement
Boehringer Ingelheim Pharmaceuticals Inc. et al v. Apotex Inc. et al
as 1:2023cv00685
Plaintiff:
Boehringer Ingelheim Pharmaceuticals Inc., Boehringer Ingelheim International GmbH, Boehringer Ingelheim Corporation and others
Defendant:
Apotex Inc. and Apotex Corp.
Cause Of Action: 35 U.S.C. § 271 Patent Infringement
Pierce v. Pfizer, Inc. et al.,
as 3:2023cv23080
Plaintiff:
Tammy Rene Pierce
Defendant:
Pfizer Inc., Boehringer Ingelheim Pharmaceuticals, Inc., Boehringer Ingelheim Corporation and others
Cause Of Action: 28 U.S.C. § 1332 Diversity
Pfizer Inc. et al v. Apotex Inc. et al
as 1:2023cv00445
Plaintiff:
Pfizer Inc., C.P. Pharmaceuticals International C.V., PF PRISM C.V. and others
Defendant:
Apotex Inc. and Apotex Corp.
Cause Of Action: 35 U.S.C. § 271 Patent Infringement
Disclaimer: Justia Dockets & Filings provides public litigation records from the federal appellate and district courts. These filings and docket sheets should not be considered findings of fact or liability, nor do they necessarily reflect the view of Justia.
